by admin | May 4, 2024 | Article
March 6, 2024 – Lupus Canada is pleased to share that Saphnelo has been listed in Nova Scotia effective March 1, 2024. The public notice and listing criteria will appear on the Nova Scotia Pharmacare Programs website when the March Bulletin is...
by admin | May 4, 2024 | Article
February 15, 2024 – Lupus Canada is honoured to be a member of the CIAN group. Together our goal is to protect more Canadians to improve the quality of life and significantly reduce hospitalization for vulnerable people. On page 60 of the Heal Canada Digital...
by admin | Apr 19, 2024 | Article
In a new study, researchers explored predictors of neuropsychiatric (brain-related) flare activity in people with lupus being treated with active disease (without ongoing or severe neuropsychiatric involvement), and found an association...
by admin | Apr 19, 2024 | Article
https://www.lupuscanada.org/wp-content/uploads/Immune-Compromised-Canadians-and-COVID-19.pdf
by admin | Apr 19, 2024 | Article
We know that the BA.4 and BA.5 are starting to circulate in Canada. These variants are even more contagious than previous omicron variants, and as a result, some regions of Canada are already seeing another wave. While it is unclear how effective a booster with the...
